QT Vascular

SINGAPORE (Sept 20): Here are some stocks that could move the market this Tuesday morning:

SINGAPORE (Sept 20): QT Vascular says it has been granted a conditional Investigational Device Exemption approval from the Food and Drug Administration to commence clinical trials for its Chocolate Touch drug-coated balloon.

SINGAPORE (Aug 26): iX Biopharma is a small Catalist-listed Singapore company focusing on a big goal: Developing pain management drugs that are an alternative to opioids, and the optimum system to deliver these drugs into the body.

SINGAPORE (July 20): QT Vascular on Monday signed a non-binding term sheet with an “international industry player” for a potential transaction relating to its Chocolate PTA Balloon Catheter assets.

SINGAPORE (July 7): QT Vascular on Thursday announced it has received CE mark clearance for the sale and distribution of the Chocolate Heart drug-coated percutaneous transluminal coronary angioplasty (PTCA) balloon in Europe.